Famta

The founders of Fam Tan Azma Company (FAMTA), specialized in the field of molecular diagnosis of infectious diseases, as well as genetic diseases and launching related tests, established a molecular diagnosis laboratory as one of the first molecular diagnostic centers in Iran since 2001. They began and came with the rapid development of molecular techniques and experiments. Also, given the long experience in the field, up to now 30 hospitals, laboratories, universities and research centers have been set up to carry out this section and a large number of centers have been set up to conduct specialized tests. Since valid molecular diagnostics kits have not been produced with the international approval in the field of infectious diseases so far and foresee the need of country and hospital and laboratory centers to launch new molecular techniques such as Digital PCR, NGS, etc., Finally, FAMATA Co. was established in 2019 with the aim of launching a leading company in the field of biotechnology, especially molecular diagnostics and meeting these needs. Mission The most important field of activity of the company is the production of molecular diagnostic kits in the field of infectious diseases, genetic and veterinary diseases, with international approval, and furthermore, the provision of specialized molecular testing equipment and materials, as well as providing specialized consulting services and molecular diagnostics and Genetics refers to academic, research, industrial centers such as the food and pharmaceutical industries, hospitals, veterinary centers and diagnostic laboratories. Short-term goals: • Receiving knowledge based certification for FEMATA Company • Obtain CE and IVD approvals for an anticipated number of production kits • Obtain exclusive representation from internationally accredited companies and import molecular testing devices and materials and molecular diagnostics • Acquiring at least 30% of the domestic market in molecular diagnostics Long term p